The role of OCT-A in retinal disease management

Optical coherence tomography angiography (OCT-A) is a non-invasive, non-dye-based imaging modality that has the potential to enhance our understanding of retinal diseases. While this rapidly advancing imaging modality offers great potential, there is a need for community-wide understanding of the ra...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2018
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/24175
Acceso en línea:
https://doi.org/10.1007/s00417-018-4109-3
https://repository.urosario.edu.co/handle/10336/24175
Palabra clave:
Age related macular degeneration
Algorithm
Blood vessel permeability
Clinical practice
Diabetic macular edema
Diagnostic test
Human
Image processing
Medical decision making
Microangiography
Optical coherence tomography angiography
Polypoidal choroidal vasculopathy
Priority journal
Publication
Retina detachment
Retina disease
Retina vein occlusion
Review
Screening
Subretinal neovascularization
Fluorescence angiography
Optical coherence tomography
Pathology
Procedures
Retina
Retina disease
Visual system examination
Fluorescein angiography
Humans
Retina
Retinal diseases
Imaging modality
Non-invasive
Oct-a
Optical coherence tomography angiography
Retinal diseases
optical coherence
ophthalmological
Diagnostic techniques
Tomography
Rights
License
Abierto (Texto Completo)
Description
Summary:Optical coherence tomography angiography (OCT-A) is a non-invasive, non-dye-based imaging modality that has the potential to enhance our understanding of retinal diseases. While this rapidly advancing imaging modality offers great potential, there is a need for community-wide understanding of the range of technologies and methods for interpreting the images, as well as a need to enhance understanding of images from disease-free eyes for reference when screening for retinal diseases. Importantly, clinical trials have been designed without OCT-A-based endpoints; therefore, caution is required when making treatment decisions based on OCT-A imaging alone. With this in mind, a full understanding of the advantages and limitations of OCT-A will be vital for effective development of the technique within the field of ophthalmology. On behalf of the Vision Academy Steering Committee (sponsored by Bayer), this publication summarizes the views of the authors on the current use of OCT-A imaging and explores its potential for future applications in research and clinical practice. © 2018, The Author(s).